Biguanidine and Triazine Synthesis with Low-Waste Solvent Pairing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for preparing indaziflam and related triazine compounds suffer from low yield, excessive waste generation, high reaction temperatures, and operationally complicated isolation processes, particularly due to the use of large amounts of aluminum alkoxide and multiple solvents.
Innovation Solution
A process involving the reaction of 1-cyanoguanidine with an amine in a mixture of a polar aprotic solvent with a dielectric constant higher than 12.0 and a water immiscible solvent, followed by the addition of a base and a carboxylic acid derivative, allows for the preparation of biguanidine and triazine compounds at reduced temperatures and improved yields, minimizing waste and simplifying isolation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If aluminum alkoxide is used in large excess to form biguanidino-aluminum complex, then the reaction can proceed at low temperature with better yield, but considerable amounts of waste are generated requiring costly and complex disposal
Solution Approach 1:
The patent removes aluminum alkoxide from the reaction system entirely, replacing it with a catalytic amount of a specific base (potassium carbonate, sodium carbonate, or cesium carbonate). This extraction of the harmful aluminum alkoxide eliminates the waste generation problem while maintaining the beneficial low-temperature reaction conditions and good yield through the alternative base-catalyzed mechanism.
Solution Approach 2:
The patent changes the fundamental parameter of the base used from aluminum alkoxide (which requires large excess and generates waste) to a different base class (potassium carbonate, sodium carbonate, or cesium carbonate) that can be used in catalytic amounts. This parameter change transforms the process from one generating considerable waste to one with minimal waste, while maintaining high productivity.
2Productivity
If multiple different solvents are used for each step, then the synthesis can be performed with better yields, but operational challenge increases while trying to recycle and isolate each solvent
Solution Approach 1:
The patent merges the solvent system into a single, consistent polar aprotic solvent (such as dimethylformamide, dimethylacetamide, N-methylpyrrolidone, or acetonitrile) that is used for both the formation of the biguanidine intermediate and the subsequent cyclization to the triazine compound. This consolidation eliminates the need to handle multiple different solvents, significantly simplifying the operational complexity while maintaining good yields through the unified reaction conditions.
3Productivity
If filtration of excess potassium carbonate salt is required, then the reaction can proceed with high yield, but isolation becomes more complicated operationally
Solution Approach 1:
The patent optimizes the base parameters by using specifically potassium carbonate, sodium carbonate, or cesium carbonate in controlled amounts, and by adjusting the solvent system and temperature conditions, the patent achieves high yields without requiring filtration of excess base. The modified reaction parameters allow the excess base to remain in solution or be easily separated, dramatically simplifying the isolation operation while maintaining high productivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process achieves high yields of biguanidine and triazine compounds while reducing reaction temperatures and minimizing waste, offering a more efficient and streamlined synthesis.
Implementation Method 1
in a mixture of a polar aprotic solvent with a dielectric constant higher than 12.0, when measured at 25° C., and a water immiscible solvent
Data Source
AI summary
A process for the preparation of biguanidine compounds of formula (I) and triazine compounds of formula (IV); wherein R1, R2 and R3 are each independently hydrogen or an optionally substituted C1-C4 alkyl group, wherein the optional substituents are selected from the group consisting of halogen, aliphatic, halo aliphatic, alicyclic, alkoxy, thioalkyl, cyano or nitro groups; A is —CH2—, —O— or a direct bond; and n is 0, 1, 2 or 3.